Effects of Cangfudaotan Tang on Expression of Organic Anion Transporting Polypeptide (oatp2b1) in Liver and Kidney Tissues of Rats with Phlegm Dampness Type Polycystic Ovary Syndrome (PCOS)
- 1 Department of Traditional Chinese Medicine, Sun Yat-Sen Memory Hospital of Sun Yat-sen University, Guangzhou, China
- 2 Department of Traditional Chinese Medicine, Sun Yat-Sen Memory Hospital of Sun Yat-sen University, Guangzhou, China
- 3 Department of Traditional Chinese Medicine, Sun Yat-Sen Memory Hospital of Sun Yat-sen University, Guangzhou, China
- 4 Department of Traditional Chinese Medicine, Sun Yat-Sen Memory Hospital of Sun Yat-sen University, Guangzhou, China
- 5 Department of Traditional Chinese Medicine, Sun Yat-Sen Memory Hospital of Sun Yat-sen University, Guangzhou, China
Abstract
Objective: To explore the effect of Cangfudaotan Tang on phlegm dampness type of PCOS and the role of oatp2b1 in transportation and transformation of phlegm dampness. Methods: 36 SD female rats were randomly divided into three groups: blank control group, model group and Cangfudaotan Tang group, 12 cases in each one. After PCOS rat models were made, rats of Cangfudaotan Tang group were treated with Cangfudaotan Tang (1.42 g/kg/d) by intragastric administration for 14 days; blank control and model group were given with isodose saline. The expression of oatp2b1 mRNA/Protein in liver and kidney tissues was measured and the level of testosterone (T), follicle stimulating hormone(FSH), estradiol (E 2 ), luteinizing hormone(LH), Serum total cholesterol (TG), Triacylglycerols (TC), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were detected at the same time. Results: Compared with blank control group, the expression of oatp2b1 mRNA and the level of TC, TG, LDL, LH, FSH, T in model group were significantly increased (P < 0. 05), while the level of HDL was significantly decreased (P < 0. 05); compared with model group, the expression of oatp2b1 mRNA and the level of TC, TG, LDL in Cangfudaotan Tang group were significantly lowered (P < 0.05); the level of HDL was significantly higher; the oatp2b1 protein in kidney and liver tissues had different degrees of expression, while there was no statistical significance among the three groups. Conclusions: Oatp2b1 might be one of the material bases participating in transportation and transformation of phlegmy dampness. The mechanism of Cangfudaotan Tang treating phlegm dampness type of PCOS may be achieved by regulating the expression of oatp2b1.
- Zair, Z.M., Eloranta, J.J., Stieger, B., et al. (2008) Pharmacogenetics of OATP (SLC21/ SLCO) OAT and OC (SLC22) and PEPY (SLC15) Transporters in the Intestine, Liver and Kidney. Pharmacogenomics, 9, 597-624. https://doi.org/10.2217/14622416.9.5.597
- Zeng, L., Zhao, H.Y. and Luo, S.P. (2010) The Study of Improving rat Polycystic Ovarian Syndrome-Insulin Resistance (PCOS-IR) Model. CJTCMP, 5, 2341-2345.
- Tan, Z.H., Li, X.J., Wu, J., et al. (2008) Study on Phlegm Dampness Syndrome in TCM with Impaired Glucose Regulation. Journal of Bright Chinese Medicine, 23, 893-895.
- Liu, T., Xu, Q.L., Yang, S.Y., et al. (2009) Establishment and Evaluation of Animal Model of Phlegm Dampness Syndrome Induced by High Fat Diet. Journal of Changchun University of Traditional Chinese Medicine, 25, 333-334.
- Tian, J.Z., Wang, Y.Y., Xu, Y., et al. (2006) The Types, Evaluation and Research of Animal Model of Blood Stasis Syndrome. Journal of Beijing University of Traditional Chinese Medicine, 29, 396-400.
- Sarr, F.S., André, C. and Guillaume, Y.C. (2010) A Novel Biochromatographic Oatp2 Column to Study the Transmembrane Transport of Statins. Journal of Pharmaceutical and Biomedical Analysis, 52, 93-98. https://doi.org/10.1016/j.jpba.2009.11.029
- Hagenbuch, B. and Gui, C. (2008) Xenobiotic Transporters of the Human Organic Anion Transporting Polypeptides (OATP) Family. Xenobiotica, 38, 778-801. https://doi.org/10.1080/00498250801986951
- Wojtal, K.A., Eloranta, J.J., Hruz, P., Gutmann, H., Drewe, J., Staumann, A., Beglinger, C., Fried, M., Kullak-Ublic, G.A. and Vavricka, S.R. (2009) Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients. Drug Metabolism and Disposition, 37, 1871-1877. https://doi.org/10.1124/dmd.109.027367
- Noé, J., Portmann, R., Brun, M.E., et al. (2007) Substrate-Dependent Drug-Drug Interactions between Gemfibrozilfluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1 and OATP1B3. Drug Metabolism and Disposition, 35, 1308-1314. https://doi.org/10.1124/dmd.106.012930
- Kalliokoski, A. and Niemi, M. (2009) Impact of OATP Transporters on Pharmacokinetics. British Journal of Pharmacology, 15, 693-705. https://doi.org/10.1111/j.1476-5381.2009.00430.x
- Hagenbuch, B. and Gui, C. (2008) Xenobiotic Transporters of the Human Organic Anion Transporting Polypeptides (OATP) Family. Xenobiotica, 38, 778-801.